Tesamorelin 5mg

Tesamorelin is a synthetic growth hormone–releasing hormone (GHRH) analogue consisting of 44 amino acids. It is engineered with a stabilising trans‑3‑hexenoyl modification to enhance receptor binding and resistance to degradation. This compound is widely used in research exploring growth hormone regulation, metabolic function, and visceral adipose tissue dynamics. Tesamorelin is ideal for advanced laboratory studies requiring precision, purity, and reproducibility.

• Product Name: Tesamorelin 5mg
• Catalogue Number: TESAMO-005
• Molecular Formula: C221H366N72O67S
• CAS Number: 218949‑48‑5
• Molecular Weight: 5135.9 g/mol
• Purity: ≥99%
• Compound Type: GHRH Analogue / Peptide
• Form: Lyophilised Peptide Powder – What is this? Read more here.

Why Is Tesamorelin of Interest to the Research Community?

Tesamorelin is a potent and highly selective GHRH analogue designed to stimulate endogenous growth hormone (GH) release. By binding to GHRH receptors in the anterior pituitary, Tesamorelin triggers a natural, pulsatile rise in GH and subsequently IGF‑1, closely mimicking physiological hormone rhythms.

Research interest in Tesamorelin has grown significantly due to its demonstrated effects on:

• Visceral fat reduction — studies show significant decreases in deep abdominal fat stores
• IGF‑1 elevation — supporting protein synthesis, repair, and metabolic balance
• Improved lipid profiles — favourable changes in triglycerides and cholesterol
• Liver health — reductions in hepatic fat content in clinical studies
• Preservation of natural GH pulsatility — unlike exogenous GH, Tesamorelin supports normal endocrine rhythms

Usage and Storage:

Tesamorelin is supplied as a lyophilised peptide powder to ensure maximum stability and ease of handling in research environments. For best results, follow our website’s detailed reconstitution and storage guidelines.

Learn more about peptide storage

Synthesis and Quality Assurance:

Our Tesamorelin is synthesised using controlled peptide manufacturing processes designed to ensure high purity, structural accuracy, and batch‑to‑batch consistency. Each batch undergoes stringent purification and analytical testing to meet the rigorous standards required for advanced scientific research.

Why Choose Simply Peptides for Tesamorelin in the UK?

Simply Peptides is committed to providing research‑grade compounds of uncompromising quality. Through direct manufacturing partnerships, we maintain full oversight of production standards and batch consistency. Researchers across the UK and internationally trust our transparent testing, rigorous quality control, and dependable supply chain.

Is This Product for Human Use?

No. This material is for research only and is not intended for human consumption or clinical applications.

External Resources for Researchers

• PubMed — Tesamorelin (search)
• Google Scholar — Tesamorelin literature

Alternative Names for Tesamorelin

• TH9507 – Development code name
• Tesamorelin Acetate
• GHRH(1‑44) analogue
• Growth Hormone Releasing Factor Analogue

Legal and Safety Information:

Simply Peptides supplies Tesamorelin strictly for scientific and research use. Our products are not intended for human consumption or clinical application. We uphold stringent quality and legal compliance standards to support the research community.

COA & Testing Reports

Certificate of Analysis (COA) & Independent Testing

Each batch of Tesamorelin is accompanied by a Certificate of Analysis (COA), verifying identity, purity, and composition using validated analytical methods. This ensures transparency and supports research integrity.

In addition to internal quality control, we commission independent third‑party analysis to confirm peptide purity, molecular weight, and absence of contaminants. These reports are available upon request to qualified research professionals.

• Batch‑specific COA are available for download or review here
• Third‑party lab testing for purity and identity confirmation are available here
• Analytical methods include HPLC, Mass Spectrometry, and Microbial Screening here

Note: All documentation is provided for research reference only and is not intended to support clinical or therapeutic claims.